Protein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: results from an ex vivo study.
about
Pharmacotherapy during pediatric extracorporeal membrane oxygenation: a review.Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine models.Pharmacokinetics and Dosing of Anti-infective Drugs in Patients on Extracorporeal Membrane Oxygenation: A Review of the Current Literature.Population pharmacokinetics of intravenous clonidine for sedation during paediatric extracorporeal membrane oxygenation and continuous venovenous hemofiltration.Evaluation of Altered Drug Pharmacokinetics in Critically Ill Adults Receiving Extracorporeal Membrane Oxygenation.Considerations for analgosedation and antithrombotic management during extracorporeal life support.Medicating patients during extracorporeal membrane oxygenation: the evidence is building.Pharmacokinetics and Safety of Micafungin in Infants Supported With Extracorporeal Membrane Oxygenation.Antifungal Extraction by the Extracorporeal Membrane Oxygenation Circuit.Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.Extracorporeal life support in cardiogenic shock: indications and management in current practice.Nurse-driven analgesia and sedation in pediatric patients with univentricular hearts requiring extracorporeal life support after first-stage palliation surgery: A pilot study.Antiepileptic drugs in critically ill patients.Optimising drug dosing in patients receiving extracorporeal membrane oxygenation.Characterization of Effects of Renal Replacement Therapy Modalities and Settings on Pharmacokinetics of Meropenem and VaborbactamPredictors of insufficient peak amikacin concentration in critically ill patients on extracorporeal membrane oxygenationPhysiologically Based Pharmacokinetic Approach to Determine Dosing on Extracorporeal Life Support: Fluconazole in Children on ECMO
P2860
Q30249512-FBA6133E-4E11-413D-AABF-60F5197E88C6Q31032098-96F1CDEC-84B4-4E55-A02F-CEC3C2CB830AQ38935160-E0F59BD4-F65E-4616-949E-E01DFC404ECAQ39025601-F87EABB5-7B9A-4F22-9FE7-0870243218C8Q39033001-A9711018-00D9-44F2-9AB8-D023F4976E32Q39169651-A552B34F-75C4-4AD1-A21F-3B1F34D0F651Q39188586-69F484A6-23C5-48E7-82F7-FDF6C494048FQ39675383-BB2A8D0F-7E4A-491F-9831-917B4BA56142Q45069269-41BFF409-1F25-496F-ADF4-F745B735FDF6Q47632337-476BCB16-0A70-4666-83BD-C9A8B5BACC78Q47653181-2E5BD6C3-8396-4C8C-87C4-1ECC33D3D8E8Q47732023-A93DEB78-41F0-4578-81F6-57C8ED99BCFEQ55190397-71D2E1DC-C55F-4403-A5CD-29419DD9317EQ55393633-373F48F9-7CE6-4F85-AC90-FCF2B89DB054Q58701126-97A791D6-E407-4A95-8268-AACBE2ABE2B1Q58766376-4CF56692-9B27-4E45-B7BB-1ABC929DBB0DQ58783779-AB18454C-3880-4126-91E0-82B75DC45D33
P2860
Protein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: results from an ex vivo study.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Protein-bound drugs are prone ...... results from an ex vivo study.
@ast
Protein-bound drugs are prone ...... results from an ex vivo study.
@en
type
label
Protein-bound drugs are prone ...... results from an ex vivo study.
@ast
Protein-bound drugs are prone ...... results from an ex vivo study.
@en
prefLabel
Protein-bound drugs are prone ...... results from an ex vivo study.
@ast
Protein-bound drugs are prone ...... results from an ex vivo study.
@en
P2093
P2860
P50
P1433
P1476
Protein-bound drugs are prone ...... results from an ex vivo study.
@en
P2093
Charles I Mcdonald
Daniel V Mullany
John F Fraser
Steven C Wallis
Sussan Ghassabian
P2860
P2888
P356
10.1186/S13054-015-0891-Z
P577
2015-04-14T00:00:00Z
P5875
P6179
1043890073